Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early clinical effect of cladribine in patients with highly active multiple sclerosis in Mexico.
Sauri-Suarez S, Quiñones S, De la Maza-Flores M, Marin-Contreras A, Playas-Pérez G, Bertado-Cortes B, Frias-Marquez F, Zuñiga-García G, Rodriguez-Leal F, Blaisdell-Vidal C, Gomez-Figueroa E. Sauri-Suarez S, et al. Among authors: gomez figueroa e. Mult Scler J Exp Transl Clin. 2024 Aug 1;10(3):20552173241260156. doi: 10.1177/20552173241260156. eCollection 2024 Jul-Sep. Mult Scler J Exp Transl Clin. 2024. PMID: 39091340 Free PMC article.
Diagnostic MRI Score to Differentiate Susac Syndrome from Primary Angiitis of the Central Nervous System and Multiple Sclerosis.
Marrodan M, Calandri IL, Bocancea DI, Ysrraelit MC, Gomez Figueroa E, Massó Páez M, Flores JDJ, Rojas JI, Ciampi E, Ioli P, Zanga G, Ardohain C, Fracaro ME, Amaya M, Tkachuk V, Fernandez VC, José G, Silva E, Luetic G, Carnero Contentti E, Köhler E, Pagani Cassara F, Moran D, Seimandi C, Paviolo JP, D'elio B, Da Prat G, Gatto E, Cristiano E, Pujol Lereis V, Ameriso SF, Fiol MP, Correale J. Marrodan M, et al. Among authors: gomez figueroa e. Ann Neurol. 2024 Nov;96(5):846-854. doi: 10.1002/ana.27043. Epub 2024 Jul 26. Ann Neurol. 2024. PMID: 39056308
Relative cerebral blood volume as response predictor in the treatment of recurrent glioblastoma with anti-angiogenic therapy.
Breda-Yepes M, Rodríguez-Hernández LA, Gómez-Figueroa E, Mondragón-Soto MG, Arellano-Flores G, Hernández-Hernández A, Rodríguez-Rubio HA, Martínez P, Reyes-Moreno I, Álvaro-Heredia JA, Gutiérrez Aceves GA, Villanueva-Castro E, Sangrador-Deitos MV, Alonso-Vanegas M, Guerrero-Juárez V, González-Aguilar A. Breda-Yepes M, et al. Among authors: gomez figueroa e. Clin Neurol Neurosurg. 2023 Oct;233:107904. doi: 10.1016/j.clineuro.2023.107904. Epub 2023 Jul 17. Clin Neurol Neurosurg. 2023. PMID: 37499302
Do Early Relapses Predict the Risk of Long-Term Relapsing Disease in an Adult and Paediatric Cohort with MOGAD?
Chen B, Gomez-Figueroa E, Redenbaugh V, Francis A, Satukijchai C, Wu Y, Messina S, Sa M, Woodhall M, Paul F, Robertson NP, Lim M, Wassmer E, Kneen R, Huda S, Blain C, Halfpenny C, Hemingway C, O'Sullivan E, Hobart J, Fisniku LK, Martin RJ, Dobson R, Cooper SA, Williams V, Waters P, Chen JJ, Pittock SJ, Ramdas S, Leite MI, Flanagan EP, Geraldes R, Palace J. Chen B, et al. Among authors: gomez figueroa e. Ann Neurol. 2023 Sep;94(3):508-517. doi: 10.1002/ana.26731. Epub 2023 Jul 12. Ann Neurol. 2023. PMID: 37394961
Clinical outcomes and prognostic factors in patients with optic neuritis related to NMOSD and MOGAD in distinct ethnic groups from Latin America.
Carnero Contentti E, López PA, Criniti J, Pettinicchi JP, Cristiano E, Patrucco L, Bribiesca Contreras E, Gómez-Figueroa E, Flores-Rivera J, Correa-Díaz EP, Toral Granda AM, Ortiz Yepez MA, Gualotuña Pachacama WA, Piedra Andrade JS, Galleguillos L, Tkachuk V, Nadur D, Daccach Marques V, Soto de Castillo I, Casas M, Cohen L, Alonso R, Caride A, Lana-Peixoto M, Rojas JI. Carnero Contentti E, et al. Among authors: gomez figueroa e. Mult Scler Relat Disord. 2023 Apr;72:104611. doi: 10.1016/j.msard.2023.104611. Epub 2023 Mar 8. Mult Scler Relat Disord. 2023. PMID: 36907119
Therapeutic strategies in NMOSD and MOGAD patients: A multicenter cohort study in Latin America.
Rojas JI, López PA, Criniti J, Pettinicchi JP, Caride A, Correa Díaz EP, Toral Granda AM, Ortiz Yepez MA, Gualotuña Pachacama WA, Andrade JSP, Daccach Marques V, Bribiesca Contreras E, Gómez Figueroa E, Flores Rivera J, Galleguillos L, Navas C, Soares Neto HR, Gracia F, Cristiano E, Patrucco L, Becker J, Hamuy F, Alonso R, Man F, Tkachuk V, Nadur D, Lana-Peixoto M, Castillo IS, Carnero Contentti E. Rojas JI, et al. Among authors: gomez figueroa e. Mult Scler Relat Disord. 2023 Mar;71:104508. doi: 10.1016/j.msard.2023.104508. Epub 2023 Jan 12. Mult Scler Relat Disord. 2023. PMID: 36738691
Impact of rituximab in Mexican patients with Multiple Sclerosis-A single-center retrospective study.
Bribiesca-Contreras E, García-Estrada C, Gómez-Figueroa E, Zertuche-Ortuño L, Rodríguez-Rivas R, Marcín-Sierra M, Delgado-Niño M, Rivas-Alonso V, Corona-Vázquez T, Flores-Rivera J. Bribiesca-Contreras E, et al. Among authors: gomez figueroa e. Mult Scler Relat Disord. 2022 Feb;58:103485. doi: 10.1016/j.msard.2021.103485. Epub 2022 Jan 4. Mult Scler Relat Disord. 2022. PMID: 35042092
Optic neuritis after COVID-19 vaccine application.
García-Estrada C, Gómez-Figueroa E, Alban L, Arias-Cárdenas A. García-Estrada C, et al. Among authors: gomez figueroa e. Clin Exp Neuroimmunol. 2022 May;13(2):72-74. doi: 10.1111/cen3.12682. Epub 2021 Nov 22. Clin Exp Neuroimmunol. 2022. PMID: 34900001 Free PMC article.
30 results